Home
COSM
COSM News

Latest Cosmos Health Inc. (COSM) News on November 15, 2024

Cosmos Health Issues Letter to Shareholders

ACCESSWIRE

3 days ago

Cosmos Health Issues Letter to Shareholders

Cosmos Health's Subsidiary CosmoFarm Achieves Record Revenue, Up 8.62% to $43 Million YTD 2024, with Gross Profit Rising 21%

ACCESSWIRE

14 days ago

Cosmos Health's Subsidiary CosmoFarm Achieves Record Revenue, Up 8.62% to $43 Million YTD 2024, with Gross Profit Rising 21%

ACCESSWIRE

2 months ago

Cosmos Health Reports Strong 160% Increase in 2024 YTD Sales on Amazon UK for Its Proprietary Brands

ACCESSWIRE

2 months ago

Cosmos Health Receives Initial Orders Exceeding $500,000 for C-Scrub in the UK; Future Orders Booked at Accelerated Pace with Strong Profitability Anticipated Due to High Profit Margins

ACCESSWIRE

2 months ago

Cosmos Health Expands Global Presence into India, a Market with Over 1.4Bn People, Through Exclusive Agreement to Distribute Virax Biolabs' Mpox PCR Detection Kits

Cosmos Health Enters Development Phase for CCDL24, an Innovative Multitargeting Product for Gastrointestinal Disorders, with a Market Size Valued at Over $37.5 Billion

ACCESSWIRE

2 months ago

Cosmos Health Enters Development Phase for CCDL24, an Innovative Multitargeting Product for Gastrointestinal Disorders, with a Market Size Valued at Over $37.5 Billion

Cosmos Health Releases 2024-2027 Updated Guidance; Projects Revenue of $155.8M and Adjusted EBITDA of $29.4M Annually by 2027, Driven by Strategic Focus on High-Margin Segments

ACCESSWIRE

2 months ago

Cosmos Health Releases 2024-2027 Updated Guidance; Projects Revenue of $155.8M and Adjusted EBITDA of $29.4M Annually by 2027, Driven by Strategic Focus on High-Margin Segments

Taglich Brothers Publishes Updated Coverage Report on Cosmos Health; Maintains Price Target of $4, Nearly 300% Above Current Share Price

ACCESSWIRE

2 months ago

Taglich Brothers Publishes Updated Coverage Report on Cosmos Health; Maintains Price Target of $4, Nearly 300% Above Current Share Price

Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc.

PR Newswire

2 months ago

Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc.

Cosmos Health Secures Exclusivity Agreement with Virax Biolabs to Distribute mpox PCR Kits across the GCC, including the UAE, Saudi Arabia, Bahrain, Kuwait, Oman, and Qatar

ACCESSWIRE

2 months ago

Cosmos Health Secures Exclusivity Agreement with Virax Biolabs to Distribute mpox PCR Kits across the GCC, including the UAE, Saudi Arabia, Bahrain, Kuwait, Oman, and Qatar

Cosmos Health Regains Full Compliance with Nasdaq Listing Requirements

ACCESSWIRE

3 months ago

Cosmos Health Regains Full Compliance with Nasdaq Listing Requirements

Cosmos Health Holds EU Distribution Rights for Virax Biolabs’ Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits

ACCESSWIRE

3 months ago

Cosmos Health Holds EU Distribution Rights for Virax Biolabs’ Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits

Cosmos Health Reports Q2 2024 Results: Sustains Positive Momentum with 7% Revenue Growth vs. Q1 2023 and 12.5% vs. H1 2023

ACCESSWIRE

3 months ago

Cosmos Health Reports Q2 2024 Results: Sustains Positive Momentum with 7% Revenue Growth vs. Q1 2023 and 12.5% vs. H1 2023

Cosmos Health Reports Q1 2024 Results: Continues to Deliver Strong Growth and Improved Performance with 18% YoY Revenue Increase and 39% Rise in Gross Profit

ACCESSWIRE

3 months ago

Cosmos Health Reports Q1 2024 Results: Continues to Deliver Strong Growth and Improved Performance with 18% YoY Revenue Increase and 39% Rise in Gross Profit

Cosmos Health Completes Registration Process in Germany to Commence Sales of its C-Scrub Antimicrobial Wash; Enters $750M+ Market

ACCESSWIRE

3 months ago

Cosmos Health Completes Registration Process in Germany to Commence Sales of its C-Scrub Antimicrobial Wash; Enters $750M+ Market

Cosmos Health Reports Full Year 2023 Results: Revenue Increases to $53.4M, or 6% YoY; Stockholders' Equity Remains Near Record Highs at $36M, or $2.25 per Share

ACCESSWIRE

3 months ago

Cosmos Health Reports Full Year 2023 Results: Revenue Increases to $53.4M, or 6% YoY; Stockholders' Equity Remains Near Record Highs at $36M, or $2.25 per Share

Cosmos Health Successfully Submits Tender for C-Scrub Wash Chlorhexidine 4% to Supply NHS Scotland

ACCESSWIRE

4 months ago

Cosmos Health Successfully Submits Tender for C-Scrub Wash Chlorhexidine 4% to Supply NHS Scotland

Cosmos Health Signs Distribution Agreement with ProMed Trading for Its Sky Premium Life Food Supplements in Qatar

ACCESSWIRE

4 months ago

Cosmos Health Signs Distribution Agreement with ProMed Trading for Its Sky Premium Life Food Supplements in Qatar

Cosmos Health Updates on Contract Manufacturing Division; Completes Phase I of Production Capacity Expansion, Positioned to Generate Over $10M in Annual Gross Profit at Full Capacity

ACCESSWIRE

4 months ago

Cosmos Health Updates on Contract Manufacturing Division; Completes Phase I of Production Capacity Expansion, Positioned to Generate Over $10M in Annual Gross Profit at Full Capacity

Cosmos Health Regains Compliance with Nasdaq Minimum Bid Price Rule

ACCESSWIRE

4 months ago

Cosmos Health Regains Compliance with Nasdaq Minimum Bid Price Rule

Cosmos Health's Cana Secures Additional Contract Manufacturing Agreement with Provident Pharmaceuticals for 700,000 Units, Bringing Total Order Book to 5.02 Million Units

ACCESSWIRE

4 months ago

Cosmos Health's Cana Secures Additional Contract Manufacturing Agreement with Provident Pharmaceuticals for 700,000 Units, Bringing Total Order Book to 5.02 Million Units

Cosmos Health Advances Commercialization of CCX0722 Weight Management Solution with Completion of Pilot Production and Scale-Up Phases; Significant Step Towards Entering $143Bn Global Market

ACCESSWIRE

4 months ago

Cosmos Health Advances Commercialization of CCX0722 Weight Management Solution with Completion of Pilot Production and Scale-Up Phases; Significant Step Towards Entering $143Bn Global Market

Cosmos Health's Cana Secures Contract Manufacturing Agreement with Australia's Humacology for up to 500,000 CBD Units Annually

ACCESSWIRE

4 months ago

Cosmos Health's Cana Secures Contract Manufacturing Agreement with Australia's Humacology for up to 500,000 CBD Units Annually

ACCESSWIRE

4 months ago

Cosmos Health Expands Collaboration with Papaellinas in Cyprus; Sky Premium Life Sales Expected to More Than Double to 150,000 Units Over Next 12 Months

Cosmos Health Signs Distribution Agreement with ZENDON s.r.o. in Slovakia, Hungary, Poland, and Czechia for Its Sky Premium Life Nutraceutical Products; Gains Access to More than 6,000 Stores of Leading Pharmacy and Retail Chains

ACCESSWIRE

4 months ago

Cosmos Health Signs Distribution Agreement with ZENDON s.r.o. in Slovakia, Hungary, Poland, and Czechia for Its Sky Premium Life Nutraceutical Products; Gains Access to More than 6,000 Stores of Leading Pharmacy and Retail Chains

Cosmos Health Signs Exclusive Distribution Agreement with Pharmalink for Its Sky Premium Life Nutraceuticals in the UAE; Receives Initial Purchase Order for 130,000 Units

ACCESSWIRE

5 months ago

Cosmos Health Signs Exclusive Distribution Agreement with Pharmalink for Its Sky Premium Life Nutraceuticals in the UAE; Receives Initial Purchase Order for 130,000 Units

Cosmos Health Strengthens Global Brain Tumor Market Position by Entering Agreement to Acquire Remaining Rights to WIPO-Filed CNS Cancer Drug Patent

ACCESSWIRE

5 months ago

Cosmos Health Strengthens Global Brain Tumor Market Position by Entering Agreement to Acquire Remaining Rights to WIPO-Filed CNS Cancer Drug Patent

Cosmos Health Completes Acquisition of Pelofarm's Pharmacy Distribution Network; Annual Revenue Poised to Grow by Over $5 Million

ACCESSWIRE

5 months ago

Cosmos Health Completes Acquisition of Pelofarm's Pharmacy Distribution Network; Annual Revenue Poised to Grow by Over $5 Million

Cosmos Health Receives Additional Delinquency Letter from Nasdaq Regarding Late Filings of Its Forms 10-K and 10-Q

ACCESSWIRE

6 months ago

Cosmos Health Receives Additional Delinquency Letter from Nasdaq Regarding Late Filings of Its Forms 10-K and 10-Q

ACCESSWIRE

6 months ago

Cosmos Health Participated in Vitafoods Europe 2024; Receives Significant Interest and Numerous New Partnership Inquiries for its Sky Premium Life Nutraceuticals Brand

Cosmos Health Receives Nasdaq Notice on Late Filing of Its Form 10-K

ACCESSWIRE

7 months ago

Cosmos Health Receives Nasdaq Notice on Late Filing of Its Form 10-K

Cosmos Health Commences Development of Cloudscreen 2.0, the New Iteration of its Next Generation AI Drug Repurposing Platform

ACCESSWIRE

8 months ago

Cosmos Health Commences Development of Cloudscreen 2.0, the New Iteration of its Next Generation AI Drug Repurposing Platform

Cosmos Health To Receive Regulatory Approval for C-Scrub Disinfectant in the UK, Obtains Initial Purchase Order; Explores Opportunities Outside EU, Eyeing Global $36Bn+ Market

ACCESSWIRE

8 months ago

Cosmos Health To Receive Regulatory Approval for C-Scrub Disinfectant in the UK, Obtains Initial Purchase Order; Explores Opportunities Outside EU, Eyeing Global $36Bn+ Market

Cosmos Health Receives Regulatory Approval to Sell Sky Premium Life Products in $1.9Bn UAE Nutritional Supplements Market; Secures Initial Purchase Orders

ACCESSWIRE

8 months ago

Cosmos Health Receives Regulatory Approval to Sell Sky Premium Life Products in $1.9Bn UAE Nutritional Supplements Market; Secures Initial Purchase Orders

Cosmos Health Successfully Completes Acquisition of Pharmatrade’s Assets; Expects to Increase FY 2024 Annual Revenue by over $5 Million

ACCESSWIRE

9 months ago

Cosmos Health Successfully Completes Acquisition of Pharmatrade’s Assets; Expects to Increase FY 2024 Annual Revenue by over $5 Million

As Trading Frenzies Grip Penny Stocks, Criticism of Nasdaq Grows

The Wall Street Journal

9 months ago

As Trading Frenzies Grip Penny Stocks, Criticism of Nasdaq Grows

Taglich Brothers Publishes First Coverage Report on Cosmos Health with a Price Target of $4, a Nearly Five-Fold Increase from Current Share Price

ACCESSWIRE

9 months ago

Taglich Brothers Publishes First Coverage Report on Cosmos Health with a Price Target of $4, a Nearly Five-Fold Increase from Current Share Price

Taglich Brothers Initiates Coverage of Cosmos Health Inc.

GlobeNewswire

9 months ago

Taglich Brothers Initiates Coverage of Cosmos Health Inc.

Cosmos Health CEO, Greg Siokas, Purchases Shares in the Open Market, Showcasing His Confidence in the Company

ACCESSWIRE

9 months ago

Cosmos Health CEO, Greg Siokas, Purchases Shares in the Open Market, Showcasing His Confidence in the Company

Earnings Preview: Sensus Healthcare, Inc. (SRTS) Q4 Earnings Expected to Decline

Zacks

9 months ago

Earnings Preview: Sensus Healthcare, Inc. (SRTS) Q4 Earnings Expected to Decline

Taglich Brothers Initiates Coverage of Cosmos Health Inc.

ACCESSWIRE

9 months ago

Taglich Brothers Initiates Coverage of Cosmos Health Inc.

Institutional investors own a significant stake of 44% in GeneDx Holdings Corp. (NASDAQ:WGS)

Simply Wall St.

10 months ago

Institutional investors own a significant stake of 44% in GeneDx Holdings Corp. (NASDAQ:WGS)

Palatin Announces $10 Million Registered Direct Offering

PR Newswire

10 months ago

Palatin Announces $10 Million Registered Direct Offering

Argus Research

10 months ago

Daily – Vickers Top Insider Picks for 01/25/2024

Cosmos Health Completes Acquisition of Cloudscreen, a Cutting-Edge AI Platform; Enters Lucrative $25Bn+ Global Drug Repurposing Market

ACCESSWIRE

10 months ago

Cosmos Health Completes Acquisition of Cloudscreen, a Cutting-Edge AI Platform; Enters Lucrative $25Bn+ Global Drug Repurposing Market

Cosmos Health Bolsters Presence in $400Bn+ Global Generic Drugs Market with $3.5M Acquisition of 10-Drug Portfolio

ACCESSWIRE

10 months ago

Cosmos Health Bolsters Presence in $400Bn+ Global Generic Drugs Market with $3.5M Acquisition of 10-Drug Portfolio

Sidoti Events, LLC's Virtual January Micro-Cap Conference

ACCESSWIRE

10 months ago

Sidoti Events, LLC's Virtual January Micro-Cap Conference

3 Growth Stocks That Could Go Parabolic in 2024

Motley Fool

10 months ago

3 Growth Stocks That Could Go Parabolic in 2024

(Updated) U.S. Legal Cannabis Pioneer Bright Green Corporation Appoints Industry Veteran Groovy Singh as New Chief Executive Officer

GlobeNewswire

10 months ago

(Updated) U.S. Legal Cannabis Pioneer Bright Green Corporation Appoints Industry Veteran Groovy Singh as New Chief Executive Officer

FreightCar America, Inc. to Present at Sidoti Micro-Cap Virtual Conference

GlobeNewswire

10 months ago

FreightCar America, Inc. to Present at Sidoti Micro-Cap Virtual Conference

GlobeNewswire

10 months ago

DayDayCook Announces Agreement to Acquire 51% of Italian G.L. Industry S.p.A, a Specialized Asian Food Brand

US Gold Corp. Issues 2024 CEO Update

PR Newswire

10 months ago

US Gold Corp. Issues 2024 CEO Update

Lichen China Limited's (NASDAQ:LICN) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?

Simply Wall St.

10 months ago

Lichen China Limited's (NASDAQ:LICN) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?

Leap Therapeutics to Participate at the 42nd Annual J.P. Morgan Healthcare Conference

PR Newswire

10 months ago

Leap Therapeutics to Participate at the 42nd Annual J.P. Morgan Healthcare Conference

Cosmos Health Set for Substantial Growth From Acquisitions Completed in 2023

ACCESSWIRE

a year ago

Cosmos Health Set for Substantial Growth From Acquisitions Completed in 2023

GlobeNewswire

a year ago

DayDayCook Announces Agreement to Acquire Leading American Ready-to-Eat Thai Food Brand Yai’s Thai

FSD Pharma Files Final Base Shelf Prospectus to Replace Expired Base Shelf Prospectus and Form F-3 Registration Statement with the SEC

ACCESSWIRE

a year ago

FSD Pharma Files Final Base Shelf Prospectus to Replace Expired Base Shelf Prospectus and Form F-3 Registration Statement with the SEC

Cidara Therapeutics Announces European Approval of REZZAYO® (rezafungin) for the Treatment of Invasive Candidiasis in Adults

GlobeNewswire

a year ago

Cidara Therapeutics Announces European Approval of REZZAYO® (rezafungin) for the Treatment of Invasive Candidiasis in Adults

Equillium Announces Update on Multi-Cytokine Inhibitors EQ101 & EQ102 in Development for Alopecia Areata and Celiac Disease

Business Wire

a year ago

Equillium Announces Update on Multi-Cytokine Inhibitors EQ101 & EQ102 in Development for Alopecia Areata and Celiac Disease

Cosmos Health Enters into Definitive Agreement to Acquire Type-2 Diabetes Treatment DIABIT-IS X

ACCESSWIRE

a year ago

Cosmos Health Enters into Definitive Agreement to Acquire Type-2 Diabetes Treatment DIABIT-IS X

Bit Digital, Inc. Announces That There Have Been No Disruptions to Its Operations in Iceland

PR Newswire

a year ago

Bit Digital, Inc. Announces That There Have Been No Disruptions to Its Operations in Iceland

3 Penny Stocks That Are Too Compelling to Ignore

InvestorPlace

a year ago

3 Penny Stocks That Are Too Compelling to Ignore

Are Medical Stocks Lagging Bausch Health (BHC) This Year?

Zacks

a year ago

Are Medical Stocks Lagging Bausch Health (BHC) This Year?

Cosmos Health Announces Open Market Stock Purchases by the CEO

ACCESSWIRE

a year ago

Cosmos Health Announces Open Market Stock Purchases by the CEO

Here Is Why Bargain Hunters Would Love Fast-paced Mover ACRES Commercial (ACR)

Zacks

a year ago

Here Is Why Bargain Hunters Would Love Fast-paced Mover ACRES Commercial (ACR)

Cosmos Health to Participate at Capital Link’s 'Invest in Greece' Forum in New York

ACCESSWIRE

a year ago

Cosmos Health to Participate at Capital Link’s 'Invest in Greece' Forum in New York

Cosmos Health Enters into Agreement to Acquire Rights for WIPO-Filed Patent on Drug Targeting CNS Cancers

ACCESSWIRE

a year ago

Cosmos Health Enters into Agreement to Acquire Rights for WIPO-Filed Patent on Drug Targeting CNS Cancers

Lilium Starts Production of the Lilium Jet in Watershed Moment for Sustainable Aviation

GlobeNewswire

a year ago

Lilium Starts Production of the Lilium Jet in Watershed Moment for Sustainable Aviation

PR Newswire

a year ago

Lixiang Education Receives Nasdaq Extension to Regain $1 Bid Price Compliance

PR Newswire

a year ago

Two Roads Advisors Successfully Represents Toy Brand WeCool and Skincare Brand QRx on Their Exits

GlobeNewswire

a year ago

DayDayCook Announces Share Repurchase Program

ACRES Commercial Realty Corp. Reauthorizes an Additional $10 Million Share Repurchase Program

PR Newswire

a year ago

ACRES Commercial Realty Corp. Reauthorizes an Additional $10 Million Share Repurchase Program

Dyadic Attends Investor Events in December

GlobeNewswire

a year ago

Dyadic Attends Investor Events in December

GlobeNewswire

a year ago

DayDayCook Announces Closing of Initial Public Offering

GlobeNewswire

a year ago

DayDayCook Announces Pricing of Initial Public Offering

Carmell Corp Announces Addition of Scott Frisch and Gilles Spenlehauer to Board of Directors

GlobeNewswire

a year ago

Carmell Corp Announces Addition of Scott Frisch and Gilles Spenlehauer to Board of Directors

Companies Like Unity Biotechnology (NASDAQ:UBX) Could Be Quite Risky

Simply Wall St.

a year ago

Companies Like Unity Biotechnology (NASDAQ:UBX) Could Be Quite Risky

BEST Inc. Receives Notice Regarding NYSE Continued Listing Standards

PR Newswire

a year ago

BEST Inc. Receives Notice Regarding NYSE Continued Listing Standards

Optex Systems Announces $1.3 Million Order for Laser Filter Units

ACCESSWIRE

a year ago

Optex Systems Announces $1.3 Million Order for Laser Filter Units

Investors Still Aren't Entirely Convinced By Nutex Health Inc.'s (NASDAQ:NUTX) Revenues Despite 27% Price Jump

Simply Wall St.

a year ago

Investors Still Aren't Entirely Convinced By Nutex Health Inc.'s (NASDAQ:NUTX) Revenues Despite 27% Price Jump

Lantern Pharma Reports Third Quarter 2023 Financial Results and Operational Highlights

Business Wire

a year ago

Lantern Pharma Reports Third Quarter 2023 Financial Results and Operational Highlights

Associated Press Finance

a year ago

Vista Gold: Q3 Earnings Snapshot

Vista Gold Corp. Announces Third Quarter Financial Results and Corporate Update

Business Wire

a year ago

Vista Gold Corp. Announces Third Quarter Financial Results and Corporate Update

BK Technologies Receives $315,000 Purchase Order from the United States Department of Defense for the BKR 9000 Multiband Radio

ACCESSWIRE

a year ago

BK Technologies Receives $315,000 Purchase Order from the United States Department of Defense for the BKR 9000 Multiband Radio

PR Newswire

a year ago

Lixiang Education Announces Receipt of Nasdaq Staff Determination Letter and Intent to Request Hearing

Territorial Bancorp (NASDAQ:TBNK) Has Announced That Its Dividend Will Be Reduced To $0.05

Simply Wall St.

a year ago

Territorial Bancorp (NASDAQ:TBNK) Has Announced That Its Dividend Will Be Reduced To $0.05

Don't Race Out To Buy Territorial Bancorp Inc. (NASDAQ:TBNK) Just Because It's Going Ex-Dividend

Simply Wall St.

a year ago

Don't Race Out To Buy Territorial Bancorp Inc. (NASDAQ:TBNK) Just Because It's Going Ex-Dividend

Better Launches Better Insurance to Provide Online Insurance Experience for American Homeowners

Business Wire

a year ago

Better Launches Better Insurance to Provide Online Insurance Experience for American Homeowners

ACRES COMMERCIAL REALTY CORP. ANNOUNCES RETIREMENT OF CHIEF FINANCIAL OFFICER DAVID J. BRYANT AND NAMES ELDRON C. BLACKWELL AS SUCCESSOR

PR Newswire

a year ago

ACRES COMMERCIAL REALTY CORP. ANNOUNCES RETIREMENT OF CHIEF FINANCIAL OFFICER DAVID J. BRYANT AND NAMES ELDRON C. BLACKWELL AS SUCCESSOR

Share on Social Networks: